Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Psychotic Disorders 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Glioblastoma 1Epilepsy 1Bipolar Disorder 1

Interventions

Sirolimus 2Temozolomide 1Sulfasalazine 1Radiotherapy 1Memantine 1Medical Marijuana 1Magnetoencephalography 1Gabapentin 1Clinical Laboratory Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Epilepsy × Gabapentin × Clear all
NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting
120 enrolled
CNS

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡